Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Beauty Health ( (SKIN) ) is now available.
On September 4, 2025, The Beauty Health Company, along with its domestic and foreign subsidiaries, entered into a Supplemental Indenture with U.S. Bank Trust Company to modify an existing indenture related to its 7.95% Convertible Senior Notes due 2028. This modification includes securing the notes with a first-priority guarantee by new foreign subsidiaries and addressing certain ambiguities in the original indenture, potentially strengthening the company’s financial structure and enhancing investor confidence.
The most recent analyst rating on (SKIN) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Beauty Health stock, see the SKIN Stock Forecast page.
Spark’s Take on SKIN Stock
According to Spark, TipRanks’ AI Analyst, SKIN is a Neutral.
The overall stock score reflects significant financial challenges, with high leverage and negative profitability weighing heavily. However, positive momentum in technical indicators, a favorable earnings call, and strategic debt refinancing provide some optimism. The valuation remains a concern due to negative earnings.
To see Spark’s full report on SKIN stock, click here.
More about Beauty Health
The Beauty Health Company operates in the beauty and health industry, focusing on providing innovative products and services that enhance personal care and wellness.
Average Trading Volume: 1,055,472
Technical Sentiment Signal: Buy
Current Market Cap: $253.7M
For detailed information about SKIN stock, go to TipRanks’ Stock Analysis page.